A primary study on the expression of estrogen receptor α36 in endometrial carcinoma tissues

Sun Lifang,Wang Jianliu,Zhang Lili
DOI: https://doi.org/10.13283/j.cnki.xdfckjz.2011.02.015
2011-01-01
Abstract:Objective:To analyzed the expression of ERα36 and clinicopathologic characteristics in endometrial carcinoma tissues.Methods:Seventy three endometrial carcinoma tissues,20 normal endometrial tissues and 9 atypical endometrial hyperplasia tissues were included in this study.ERα36 protein expressions were detected by immunohistochemistry methods.Results:The rate of positive expression of ERα36 in endometrial carcinoma tissues was significant lower than that of in normal endometrial tissues(P<0.01).ERα36-negative tissues were inclined to cervical involvement(24/49) and were significantly different with ERα36-positive ones(P<0.05).Disease-free survival of the patients with ERα36-positive expression was poorer than that of with ERα36-negative expression(P<0.01).There was no significant relationship between ERα36 expression and patient's age,surgical staging,histological differentiation,myometrial invasion,lymph node metastasis and pathological types(P>0.05).The expression of ERα36 had no correlation with that of the expressions of ER,PR,PTEN and p53 in endometrial carcinoma tissues(P>0.05).Conclusion:The expressions of ERα36 in endometrial carcinoma tissues are significantly lower than those in normal endometrial tissues.ERα36 expression has no correlation with ER expression,which may be a prognosis factor in endometrial carcinoma.
What problem does this paper attempt to address?